Abzena's Best-in-Class Biologics & Bioconjugate CDMO+CRO Services
At Abzena, our focus is on providing a de-risked and streamlined development pathway for our customers. As the leading CDMO + CRO for complex biologics and bioconjugates and ADCs, we support customers with fully integrated programs or individual tailored services that span from early-stage research and discovery through commercial launch to ensure that your program progresses smoothly through the critical path and rapidly advances to its next milestone.
Abzena
-
US
-
2018On CPHI since
-
3Certificates
-
500 - 999Employees
Other Content from Abzena (1)
-
News CPHI Podcast Series: The power of proteins in antibody drug development
In the latest episode of the CPHI Podcast Series, Lucy Chard is joined by Thomas Cornell from Abzena to discuss protein engineering for drug design and development.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance